Vannata B - Search Results

1

Bacterial infection-driven lymphomagenesis.

Vannata B, Pirosa MC, Bertoni F, Rossi D, Zucca E. Vannata B, et al. Curr Opin Oncol. 2022 Sep 1;34(5):454-463. doi: 10.1097/CCO.0000000000000886. Epub 2022 Jul 25. Curr Opin Oncol. 2022. PMID: 35880463 Review.

2

Emerging role of infectious etiologies in the pathogenesis of marginal zone B-cell lymphomas.

Zucca E, Bertoni F, Vannata B, Cavalli F. Zucca E, et al. Among authors: vannata b. Clin Cancer Res. 2014 Oct 15;20(20):5207-16. doi: 10.1158/1078-0432.CCR-14-0496. Clin Cancer Res. 2014. PMID: 25320370 Review.

3

Management of the marginal zone lymphomas.

Vannata B, Stathis A, Zucca E. Vannata B, et al. Cancer Treat Res. 2015;165:227-49. doi: 10.1007/978-3-319-13150-4_9. Cancer Treat Res. 2015. PMID: 25655612 Review.

4

Hepatitis C virus-associated B-cell non-Hodgkin lymphomas.

Vannata B, Zucca E. Vannata B, et al. Hematology Am Soc Hematol Educ Program. 2014 Dec 5;2014(1):590-8. doi: 10.1182/asheducation-2014.1.590. Epub 2014 Nov 18. Hematology Am Soc Hematol Educ Program. 2014. PMID: 25696916 Review.

5

Primary extranodal B-cell lymphoma: current concepts and treatment strategies.

Vannata B, Zucca E. Vannata B, et al. Chin Clin Oncol. 2015 Mar;4(1):10. doi: 10.3978/j.issn.2304-3865.2014.12.01. Chin Clin Oncol. 2015. PMID: 25841717 Free article. Review.

6

Late relapse in patients with diffuse large B-cell lymphoma: impact of rituximab on their incidence and outcome.

Vannata B, Conconi A, Winkler J, Cascione L, Margiotta Casaluci G, Nassi L, Moia R, Pirosa MC, Moccia AA, Stathis A, Rossi D, Gaidano G, Zucca E. Vannata B, et al. Br J Haematol. 2019 Nov;187(4):478-487. doi: 10.1111/bjh.16106. Epub 2019 Aug 5. Br J Haematol. 2019. PMID: 31385291 Free article.

7

Hepatitis C virus-associated B-cell non-Hodgkin's lymphomas: what do we know?

Vannata B, Arcaini L, Zucca E. Vannata B, et al. Ther Adv Hematol. 2016 Apr;7(2):94-107. doi: 10.1177/2040620715623924. Epub 2015 Dec 29. Ther Adv Hematol. 2016. PMID: 27054025 Free PMC article. Review.

8

A phase II trial of bendamustine in combination with ofatumumab in patients with relapsed or refractory marginal zone B-cell lymphomas.

Vannata B, Vanazzi A, Negri M, Liptrott SJ, Bartosek AA, Miani M, Di Sanzo A, Cavalli F, Zucca E, Stathis A. Vannata B, et al. Hematol Oncol. 2021 Feb;39(1):60-65. doi: 10.1002/hon.2822. Epub 2020 Nov 6. Hematol Oncol. 2021. PMID: 33103778 Clinical Trial.

9

A Rare Case of Classical Hodgkin Lymphoma Diagnosed 10 Years after Liver Transplant.

Zhang L, Pereira Mestre R, Bihl F, Bühler M, Vannata B, Stathis A. Zhang L, et al. Among authors: vannata b. Case Rep Oncol. 2017 Oct 17;10(3):923-927. doi: 10.1159/000481452. eCollection 2017 Sep-Dec. Case Rep Oncol. 2017. PMID: 29279693 Free PMC article.

10

Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments.

Laurenti L, Innocenti I, Autore F, Vannata B, Efremov DG, Ciolli S, Del Poeta G, Mauro FR, Cortelezzi A, Borza PA, Ghio F, Mondello P, Murru R, Gozzetti A, Cariccio MR, Piccirillo N, Boncompagni R, Cantonetti M, Principe MI, Reda G, Bongarzoni V, Cervetti G, Pitini V, Foà R, Sica S, D'Arena G. Laurenti L, et al. Among authors: vannata b. Leuk Res. 2015 Oct;39(10):1066-70. doi: 10.1016/j.leukres.2015.07.009. Epub 2015 Jul 26. Leuk Res. 2015. PMID: 26307523

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

30 results

Search Page